Article
Less common genotype variants of TP53 polymorphisms are associated with poor outcome in adult patients with adrenocortical carcinoma.
European journal of endocrinology - 1 May 2014
Heinze Britta, Herrmann Leonie J M, Fassnacht Martin, Ronchi Cristina L, Willenberg Holger S, Quinkler Marcus, Reisch Nicole, Zink Martina, Allolio Bruno, Hahner Stefanie
Abstract excerpt
CONTEXT: The Li-Fraumeni tumor syndrome is strongly associated with adrenocortical carcinoma (ACC) and is caused by germline mutations in TP53 in 70% of cases. Also, TP53 polymorphisms have been shown to influence both cancer risk and clinical outcome in several tumor entities. We, therefore, investigated TP53 polymorphisms in a cohort of adult patients with ACC. OBJECTIVE: Evaluation of the role of TP53...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
